Spillover Effect of Opioid Reduction Interventions From Adult to Pediatric Surgery

Lauren M McGee1, Ajay Kolli1, Calista M Harbaugh2

  • 1University of Michigan Medical School, Ann Arbor, Michigan.

Insights

Adult opioid prescribing guidelines did not reduce pediatric opioid use. Further research is needed for tailored pediatric guidelines to minimize opioid overprescribing in children.

Area of Science:

  • Pediatric Surgery
  • Pain Management
  • Pharmacology

Background:

  • Adult surgical patients have seen reduced opioid overprescribing due to guidelines and trainee education.
  • Tailored interventions for pediatric patients are lacking.
  • The impact of adult-focused interventions on pediatric opioid prescribing at shared institutions is unknown.

Purpose of the Study:

  • To assess the effect of adult opioid prescribing guidelines and trainee education on pediatric opioid prescribing.
  • To compare opioid prescribing patterns before and after the intervention in pediatric surgical patients.
  • To evaluate changes in opioid doses, refills, and emergency department visits post-intervention.

Main Methods:

  • Retrospective study of pediatric patients (<18 years) undergoing surgery (PS, ENT, URO).
  • Opioid prescribing data collected before (Jan 2015-Sep 2016) and after (Jan 2017-Mar 2018) intervention.
  • Chi-squared tests, t-tests, and interrupted time-series analyses (ITSA) were used for comparisons.

Main Results:

  • Fewer pediatric patients received opioids post-intervention (ENT: 97% to 93%, URO: 98% to 94%, PS: 61% to 25%).
  • Prescribed opioid doses decreased significantly across all pediatric subspecialties.
  • No significant changes were observed in opioid refill rates or postoperative emergency department visits.

Conclusions:

  • Adult-focused opioid prescribing interventions did not lead to significant reductions in pediatric opioid prescribing.
  • Declining opioid prescribing did not increase postoperative emergency department visits or refills, suggesting minimal risk.
  • Evidence-based, procedure-specific guidelines tailored for pediatric patients are necessary to curb overprescribing.
Abstract

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
838
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
786
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.4K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.8K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
168
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
202